There is a big difference, please read carefully
I have been engaged in pharmaceutical data analysis in the pharmaceutical field for many years, a few days ago in the understanding of the VBP drug banding procurement related matters met some of the Internet is not a good way to find answers to the question, which I will be sorted out and answered, and I hope to be able to help you in the work, improve work efficiency.
①What is Volume-Based Purchasing (VBP) and what does VBP mean?
Answer: Drug volume-based procurement is to publicize the required drugs and procurement volume in the bidding announcement;
And VBP is the abbreviation of volume-based procurement, which is translated as 'volume-based procurement' in Chinese, and VBP drugs are the meaning of drug volume-based procurement, and similarly VBP consumables, VBP devices means medical consumables volume-based procurement and medical equipment volume-based procurement.
②What is the difference between state procurement, volume purchasing and centralized purchasing?
A: The centralized procurement of drugs can be divided into national collection, local collection. The national centralized procurement batch has 4+7 pilot, 4+7 expansion, the Nth batch of centralized procurement; the local centralized procurement batch can be seen in the following chart
Image source: drug rongyun - centralized procurement of drugs
National procurement: can be understood as the national organization of centralized procurement
Collective procurement: the full name of centralized purchasing, because of centralized purchasing of medicines in the bidding stage did not specify the amount of demand, so even if the Pharmaceutical companies after winning the bid does not mean that there is an actual transaction, often also need to hospitals to carry out '? Second public relations', and hospitals also have the right to choose their own drug companies can be 'second bargaining', the two did not talk about is the so-called 'recruitment but not procurement'.
Band purchasing: It has been explained above, that is, in the bidding announcement to publicize the need for drugs and procurement volume. Its emergence is built on centralized purchasing, because with a clear requirement for the number of commodities, it eliminates the gray space that occurs in centralized purchasing, and realizes the unity of recruiting and purchasing. For enterprises because they can calculate the specific costs and profits, naturally under the pressure of competition will give a more favorable price; and hospitals do not need to be tedious to carry out the 'second bargaining' can also promote the standardization of bid evaluation.
③What is the VBP drug banding procurement process?
A: for bidding commission - > the establishment of the project implementation working group - > the preparation of the implementation plan - > organization of the preparation of tender documents - > the publication of tender notices - > send invitations to tender - > the sale of bidding documents - > pre-bid query meeting - > organization of bidding - > establishment of the bid evaluation committee - > public opening of the bid - > public bid evaluation committee - > public bid evaluation committee - > the bid evaluation committee - > the bid evaluation committee - > bid evaluation committee - > gt; public bid opening, bid evaluation, bidding - & gt; issued a notice of award - & gt; filing, archiving
(Note: pharmaceutical companies in the bidding process, in addition to considering the price also need to consider their own whether they can afford to correspond to the amount of production)
4 national drug banding procurement catalog information publicized on the what website? What is the website where the information of each province's drug purchasing catalog is announced?
A: The national procurement information is generally publicized on the Shanghai Sunshine Purchasing Network; the provincial drug procurement is generally released by the local or provincial alliance of a provincial leader, and its information is publicized on the official website of the leading province's drug procurement.
⑤vbp drug band purchasing data analysis methods & reports?
Answer: For pharmaceutical enterprises, the data analysis of Vbp drug banding procurement needs to rely on the past public information of each organization, through its historical public information to find out the collection of the target drugs in the geographic region of the bidding companies, prices, compared with their own products to analyze the strengths and weaknesses of their own, such as geographical differences, production costs, historical winning prices, annual profitability and other factors to analyze, can be for the later bidding price basis
Because of its data analysis involves different geographic regions, different batches, different bidding enterprise information, so the amount of data information is also very huge, and pharmaceutical companies are generally analyzed through the professional pharmaceutical data tools to improve the efficiency of the research.
As widely used by pharmaceutical companies, the drug integration cloud pharmaceutical database - the database is specialized in collecting national drug centralized purchasing information, according to the name of the drug and the name of the enterprise to summarize the information from multiple perspectives, to provide the name of the drug, the smallest unit price, specifications, dosage form, the reported amount, the supply of each province, and other dimensions of the information It also provides information on the minimum unit price, specifications, dosage form, quantity quoted, supply by province, and other dimensional information, which helps pharmaceutical companies to have an overview of the entire quantity quoted, winning bids, and supply results, and provides reference for the next centralized procurement.
Image source: PharmaEssentia Centralized Purchasing
Image source: PharmaEssentia Bidding Database
In addition, the tool's centralized purchasing database can also be linked with the consistency evaluation progress database to help users assess the competitiveness of their products and their eligibility for centralized purchasing in conjunction with enterprises that have already been or are in the process of undergoing evaluations.
Photo credit: Drug Fusion Cloud - Consistency Evaluation Review
6 Drug Band Purchasing Policy?
A: On February 11, 2022, the State Council Information Office held a regular briefing on State Council policies, inviting Chen Jinfu, deputy director of the State Medical Security Bureau, Zhou Jian, head of the Department of Consumer Goods Industry of the Ministry of Industry and Information Technology, Wang Xuetao, head of the Department of Pharmaceutical Affairs of the State Health Commission, and Li Maozhong, head of the Department of Pharmaceutical Supervision and Administration of the State Drug Administration, to introduce the progress of deepening the reform of the centralized purchasing of medicines and high-value medical consumables. The progress of the band purchasing reform.
Ⅰ. Promote the centralized band purchasing normalization, institutionalization and speed up the expansion
Mainly reflected in three aspects: the first is the speed of varieties, the second is the collection of the expansion of the coverage of the field of expansion and expansion, and the third is to continue to increase the effectiveness of the expansion of the people's benefit.
II. Guarantee a stable supply of selected drugs and high-value medical supplies
Can also be summarized in three areas: first, the opening of the national centralized purchasing of drugs to monitor the production dynamics, the second is to coordinate and solve the practical difficulties faced by enterprises, and the third is to continue to enhance the production and supply of national centralized purchasing of drugs to ensure the ability.
III.
Strengthening the supervision of product quality in the centralized purchasing
Strengthening the supervision of product quality in the centralized purchasing ensures that the price reduction does not reduce the quality. In the consistency evaluation of generic drugs, first, the establishment of a green channel for registration applications, and second, strict technical standards for the consistency evaluation of generic drug quality, and third, the formulation of the "chemical generic reference preparation selection and determination procedures". In the collection of selected drugs quality supervision, first, issued a full-coverage supervision of enterprises, selected products, sampling and testing work program, the second is the establishment of drug variety file information system, the third is to promote the collection of selected drugs traceability management.